DSM provides 2009 and Q1-Q3 2010 comparative figures
(Thomson Reuters ONE) -
Royal DSM N.V. today provides the investment community with comparative
quarterly figures for 2009 and the first nine months of 2010.
These comparative figures are a result of the today announced divestment of
Keltan(®), and the previously announced and finalized divestment of
Thermoplastic Elastomers (Sarlink(®)). Both businesses formed the business group
DSM Elastomers. Thermoplastic Elastomers (Sarlink(®)) was already classified as
held for sale in the balance sheet as per September 30, 2010 but did not
represent a discontinued operation.
The comparative figures reflect the reclassification of the complete business
group DSM Elastomers from the Base Chemicals and Materials cluster to assets
held for sale and discontinued operations. It also reflects the reclassification
of the remaining activities of the Base Chemicals and Materials cluster to Other
activities.
With the announced divestment of the remaining part of DSM Elastomers
(Keltan(®)), DSM will stop to report on the Base Chemicals and Materials
cluster, as announced earlier.
The comparative figures can be found in the annex to this press release and can
also be downloaded from the Investors section on the DSM corporate website,
www.dsm.com.
DSM - the Life Sciences and Materials Sciences Company
Royal DSM N.V. creates solutions that nourish, protect and improve performance.
Its end markets include human and animal nutrition and health, personal care,
pharmaceuticals, automotive, coatings and paint, electrical and electronics,
life protection and housing. DSM manages its business with a focus on the triple
bottom line of economic performance, environmental quality and social
responsibility, which it pursues simultaneously and in parallel. DSM has annual
net sales of about ?8 billion and employs some 22,700 people worldwide. The
company is headquartered in the Netherlands, with locations on five continents.
DSM is listed on Euronext Amsterdam. More information: www.dsm.com .
For more information:
DSM Corporate Communications DSM Investor Relations
Herman Betten Hans Vossen
tel. +31 (0) 45 5782017 tel. +31 (0) 45 5782864
fax +31 (0) 45 5740680 fax +31 (0) 45 5782595
e-mail media.relations(at)dsm.com e-mail investor.relations(at)dsm.com
Restatement-pdf:
http://hugin.info/130663/R/1471965/408586.pdf
Press release-pdf:
http://hugin.info/130663/R/1471965/408585.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: DSM N.V. via Thomson Reuters ONE
[HUG#1471965]
Unternehmensinformation / Kurzprofil:
Datum: 14.12.2010 - 07:15 Uhr
Sprache: Deutsch
News-ID 49661
Anzahl Zeichen: 3469
contact information:
Town:
Heerlen
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 429 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DSM provides 2009 and Q1-Q3 2010 comparative figures"
steht unter der journalistisch-redaktionellen Verantwortung von
DSM N.V. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
